Late infantile neuronal ceroid lipofuscinosis (Jansky-Bielchowsky disease) is a rare disease caused by mutations in the CLN2 gene. The authors report the clinical outcome and correlate with genotype in 12 Spanish patients with this disease. Psychomotor regression, epilepsy, and other clinical symptoms/signs were assessed. Age at onset of clinical symptoms ranged from 18 months to 3.7 years, and they included delayed speech and simple febrile seizures followed by epilepsy. Partial seizures and myoclonic jerks occurred at an earlier age (median 3.4 and 3.7 years, respectively) than ataxia and cognitive decline (median 4 years). Clinical regression was initiated by loss of sentences (median 3.7 years) followed by loss of walking ability and absence of language (median 4.5 years). Patients showed blindness and lost sitting ability at similar age (median 5 years). The authors report 4 novel mutations in the CLN2 gene. This study provides detailed information about the natural history of this disease.
GoebelHHSharpJD. The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol. 1998;8:151–162.
2.
WilliamsREGottlobILakeBD. CLN2, Classic late infantile NCL. In: GoebelHHMoleSELakeBD, eds. The Neuronal Ceroid Lipofuscinosis (Batten Disease). On behalf of the European Concerted Action Group. Amsterdam: IOS Press; 1999:37–54.
3.
WisniewskiKEKidaEConnellFZhongN. Neuronal ceroid lipofuscinoses: research update. Neurol Sci. 2000;21(3suppl):S49–S56.
4.
ClaussenMHeimPKnispelJ. Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet. 1992;42:536–538.
5.
UvebrantPHagbergB.Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics. 1997;28:6–8.
6.
SharpJDWheelerRBLakeBD. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum Mol Genet. 1997;6:591–595.
7.
SleatDEDonnellyRJLacklandH. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 1997;277:1802–1805.
8.
MoleSEWilliamsREGoebelHH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6:107–126.
9.
WisniewskiKEZhongNPhilippartM. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses. Neurology. 2001;57:576–581.
10.
HaltiaM. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 2003;62:1–13.
11.
WisniewskiKEKaczmarskiAKidaE. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab. 1999;66:248–252.
12.
HartikainenJMJuWWisniewskiKE. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol Genet Metab. 1999;67:162–168.
13.
EllederMDvorakovaLStolnajaL. Atypical CLN2 with later onset and prolonged course: a neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency. Acta Neuropathol. 2008;116:119–124.
14.
KohanRCismondiIAKremerRD. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Clin Genet. 2009;76:372–382.
15.
BessaCTexeiraCADiasA. CLN2/TPP1 deficiency: the novel mutation IVS7-10A>G causes intron retention and is associated with a mild disease phenotype. Mol Genet Metab. 2008;93:66–73.
16.
JuWZhongRMooreS. Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles. J Med Genet. 2002;39:822–825.
17.
SimonatiASantorumETessaA. A CLN2 gene nonsense mutation is associated with severe caudate atrophy and dystonia in LINCL. Neuropediatrics2000;31:199–201.
18.
ZhongNWisniewskiKEHartikainenJ. Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis. Clin Genet. 1998;54:234–238.
19.
SleatDEGinRMSoharI. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet. 1999;64:1511–1523.
20.
SteinfeldRHeimPvon GregoryH. Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet. 2002;112:347–354.
21.
WorgallSKekatpureMVHeierL. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. Neurology. 2007;69:521–535.
22.
Perez-PoyatoMSMila RecansensMFerrer AbizandaI. Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients. J Inherit Metab Dis. 2011;34:1083–1093.
23.
LowryOHRosebroughNJFarrALRandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
24.
GoebelHHWisniewskiKE. Current state of clinical and morphological features in human NCL. Brain Pathol. 2004;14:61–69.
25.
ZhongNMoroziewiczDNJuW. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis. Genet Med. 2000;2:312–318.
26.
TopcuMTanHYalnizogluD. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr. 2004;46:1–10.
27.
EllederMFrancJKrausJ. Neuronal ceroid lipofuscinosis in the Czech Republic: analysis of 57 cases. Report of the “Prague NCL group.”Eur J Paediatr Neurol. 1997;1:109–114.
28.
BarisicNLoganPPikijaS. R208X mutation in CLN2 gene associated with reduced cerebrospinal fluid pterins in a girl with classic late infantile neuronal ceroid lipofuscinosis. Croat Med J. 2003;44:489–493.
29.
SantavuoriPVanhanenSLAuttiT. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol. 2001;5(suppl A):157–161.
30.
KoCHKongCKChowTCLeeKC. Classic late infantile neuronal ceroid lipofuscinosis in a Chinese patient. Hong Kong Med J. 2001;7:93–96.
31.
LavrovAYIlynaESZakharovaEY. The first three Russian cases of classical, late-infantile, neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol. 2002;6:161–164.
32.
TeixeiraCGuimaraesABessaC. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. J Neurol. 2003;250:661–667.
